Desjardins Global Asset Management Inc. Abiomed Inc Transaction History

Desjardins Global Asset Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$242.49 - $301.46 $16,246 - $20,197	-67 Reduced 5.15%	1,234 $303,000
Q1 2022 May 12, 2022	SELL	$277.25 - $366.29 $8,872 - $11,721	-32 Reduced 2.4%	1,301 $430,000
Q4 2021 Jan 31, 2022	BUY	$300.63 - $371.35 $400,739 - $495,009	1,333 New	1,333 $478,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Desjardins Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Desjardins Global Asset Management Inc. with notifications on news.